Marquette General Cancer Center

 

Head and Neck

 

Study Name - RTOG 0522

 

Study Description -
A RANDOMIZED PHASE III TRIAL OF CONCURRENT ACCELERATED RADIATION AND CISPLATIN VERSUS CONCURRENT ACCELERATED RADIATION, CISPLATIN, AND CETUXIMAB (C225) [FOLLOWED BY SURGERY FOR SELECTED PATIENTS] FOR STAGE III AND IV HEAD AND NECK CARCINOMAS

 

IRB Open Date - 11-22-2005

 

Consent-Form

 

Data Privacy Statement for Research Studies

<< Back